QIAGEN Acquires Biosystems Business from Biotage
Transaction adds fundamental assay technology for high-resolution sequence detection and quantification of genetic variations
06-Oct-2008 -
QIAGEN N.V. announced that it has acquired all assets related to the Biosystems business from Biotage AB, a publicly listed developer, manufacturer and distributor of products for genetic analysis and medicinal chemistry headquartered in Uppsala, Sweden. The transaction is valued at approximately ...
bacteria
bases
Biotage
+22